AU1014695A
(en)
*
|
1994-02-17 |
1995-08-24 |
Collagen Corporation |
Collagen-synthetic polymer conjugates having controlled fiber size distributions
|
EP0713707A1
(de)
*
|
1994-11-23 |
1996-05-29 |
Collagen Corporation |
Injizierbare, in Situ vernetzbare Kollagenszusammensetzung für die Weichgewebevermehrung
|
US7871637B2
(en)
|
1996-08-27 |
2011-01-18 |
Baxter International Inc. |
Dry hemostatic compositions and methods for their preparation
|
US6066325A
(en)
|
1996-08-27 |
2000-05-23 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
US8603511B2
(en)
|
1996-08-27 |
2013-12-10 |
Baxter International, Inc. |
Fragmented polymeric compositions and methods for their use
|
US7320962B2
(en)
|
1996-08-27 |
2008-01-22 |
Baxter International Inc. |
Hemoactive compositions and methods for their manufacture and use
|
US6063061A
(en)
*
|
1996-08-27 |
2000-05-16 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
US7435425B2
(en)
*
|
2001-07-17 |
2008-10-14 |
Baxter International, Inc. |
Dry hemostatic compositions and methods for their preparation
|
US8303981B2
(en)
|
1996-08-27 |
2012-11-06 |
Baxter International Inc. |
Fragmented polymeric compositions and methods for their use
|
US6706690B2
(en)
|
1999-06-10 |
2004-03-16 |
Baxter Healthcare Corporation |
Hemoactive compositions and methods for their manufacture and use
|
GB2345638A
(en)
*
|
1998-09-11 |
2000-07-19 |
Tissue Science Lab Limited |
Injectable collagen compositions
|
US6264987B1
(en)
*
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
US6495164B1
(en)
*
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US6471995B1
(en)
*
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
US9080146B2
(en)
|
2001-01-11 |
2015-07-14 |
Celonova Biosciences, Inc. |
Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
|
US7105182B2
(en)
*
|
2001-07-25 |
2006-09-12 |
Szymaitis Dennis W |
Periodontal regeneration composition and method of using same
|
US20040028676A1
(en)
*
|
2002-08-06 |
2004-02-12 |
Klein Dean A. |
Swallowing system tissue modifier
|
CN1310946C
(zh)
*
|
2002-12-18 |
2007-04-18 |
和康生物科技股份有限公司 |
注射性胶原蛋白的制备方法及其产品
|
FR2850282B1
(fr)
|
2003-01-27 |
2007-04-06 |
Jerome Asius |
Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
|
FR2861734B1
(fr)
|
2003-04-10 |
2006-04-14 |
Corneal Ind |
Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
|
US8834864B2
(en)
*
|
2003-06-05 |
2014-09-16 |
Baxter International Inc. |
Methods for repairing and regenerating human dura mater
|
US7927626B2
(en)
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
US20090148527A1
(en)
*
|
2007-12-07 |
2009-06-11 |
Robinson Michael R |
Intraocular formulation
|
SI2409707T1
(sl)
|
2004-04-15 |
2015-07-31 |
Alkermes Pharma Ireland Limited |
Naprava s podaljšanim sproščanjem na osnovi polimerov
|
JP4694163B2
(ja)
*
|
2004-07-26 |
2011-06-08 |
株式会社ジーシー |
生体吸収性顆粒状多孔質骨補填材の製造方法
|
US9114162B2
(en)
|
2004-10-25 |
2015-08-25 |
Celonova Biosciences, Inc. |
Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
|
US20210299056A9
(en)
|
2004-10-25 |
2021-09-30 |
Varian Medical Systems, Inc. |
Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
|
US9107850B2
(en)
|
2004-10-25 |
2015-08-18 |
Celonova Biosciences, Inc. |
Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
|
ATE503465T1
(de)
|
2004-10-25 |
2011-04-15 |
Celonova Biosciences Germany Gmbh |
Beladbare polyphosphazenhaltige teilchen für therapeutische und/oder diagnostische anwendungen sowie herstellungs- und verwendungsverfahren dafür
|
US20060100138A1
(en)
*
|
2004-11-10 |
2006-05-11 |
Olsen David R |
Implantable collagen compositions
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
US8299025B2
(en)
|
2005-02-03 |
2012-10-30 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
CA2651941C
(en)
*
|
2006-05-31 |
2015-02-17 |
Baxter International Inc. |
Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
|
TWI436793B
(zh)
*
|
2006-08-02 |
2014-05-11 |
Baxter Int |
快速作用之乾密封膠及其使用和製造方法
|
KR101200728B1
(ko)
|
2006-08-09 |
2012-11-13 |
인타르시아 세라퓨틱스 인코포레이티드 |
삼투성 전달 시스템 및 피스톤 조립체
|
JP2010522196A
(ja)
*
|
2007-03-22 |
2010-07-01 |
アルカームズ,インコーポレイテッド |
コアセルベーション工程
|
WO2008147867A2
(en)
*
|
2007-05-23 |
2008-12-04 |
Allergan, Inc. |
Cross-linked collagen and uses thereof
|
WO2008157540A1
(en)
*
|
2007-06-20 |
2008-12-24 |
Alkermes, Inc. |
Quench liquids and washing systems for production of microparticles
|
US8697044B2
(en)
|
2007-10-09 |
2014-04-15 |
Allergan, Inc. |
Crossed-linked hyaluronic acid and collagen and uses thereof
|
CA2703103C
(en)
|
2007-10-30 |
2017-05-09 |
Baxter Healthcare S.A. |
Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
|
WO2009065116A1
(en)
|
2007-11-16 |
2009-05-22 |
Aspect Pharmaceuticals Llc |
Compositions and methods for treating purpura
|
US8394784B2
(en)
|
2007-11-30 |
2013-03-12 |
Allergan, Inc. |
Polysaccharide gel formulation having multi-stage bioactive agent delivery
|
US20090143348A1
(en)
*
|
2007-11-30 |
2009-06-04 |
Ahmet Tezel |
Polysaccharide gel compositions and methods for sustained delivery of drugs
|
US8394782B2
(en)
|
2007-11-30 |
2013-03-12 |
Allergan, Inc. |
Polysaccharide gel formulation having increased longevity
|
US8167787B2
(en)
|
2008-01-03 |
2012-05-01 |
Revent Medical, Inc. |
Partially erodable systems for treatment of obstructive sleep apnea
|
EP2240155B1
(de)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
|
US8642831B2
(en)
|
2008-02-29 |
2014-02-04 |
Ferrosan Medical Devices A/S |
Device for promotion of hemostasis and/or wound healing
|
EP2291152A4
(de)
|
2008-05-12 |
2015-05-06 |
Revent Medical Inc |
Teilweise erodierbare systeme zur behandlung von obstruktiver schlafapnoe
|
US9439801B2
(en)
|
2012-06-29 |
2016-09-13 |
Revent Medical, Inc. |
Systems and methods for treatment of sleep apnea
|
EP3357519B1
(de)
*
|
2008-07-02 |
2019-03-13 |
Allergan, Inc. |
Zusammensetzungen für weichgewebeauffüllung und weichgeweberegeneration
|
US8357795B2
(en)
|
2008-08-04 |
2013-01-22 |
Allergan, Inc. |
Hyaluronic acid-based gels including lidocaine
|
ES2829971T3
(es)
|
2008-09-02 |
2021-06-02 |
Tautona Group Lp |
Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos y usos de los mismos
|
US9039783B2
(en)
*
|
2009-05-18 |
2015-05-26 |
Baxter International, Inc. |
Method for the improvement of mesh implant biocompatibility
|
KR101699992B1
(ko)
|
2009-06-16 |
2017-01-26 |
백스터 인터내셔널 인코포레이티드 |
지혈용 스펀지
|
HUE035862T2
(en)
|
2009-09-28 |
2018-05-28 |
Intarcia Therapeutics Inc |
Rapid development and / or completion of substantially steady-state drug delivery
|
JP2013514093A
(ja)
|
2009-12-16 |
2013-04-25 |
バクスター・インターナショナル・インコーポレイテッド |
止血スポンジ
|
US9114188B2
(en)
|
2010-01-13 |
2015-08-25 |
Allergan, Industrie, S.A.S. |
Stable hydrogel compositions including additives
|
US20110171286A1
(en)
*
|
2010-01-13 |
2011-07-14 |
Allergan, Inc. |
Hyaluronic acid compositions for dermatological use
|
US20110171311A1
(en)
*
|
2010-01-13 |
2011-07-14 |
Allergan Industrie, Sas |
Stable hydrogel compositions including additives
|
US20110172180A1
(en)
|
2010-01-13 |
2011-07-14 |
Allergan Industrie. Sas |
Heat stable hyaluronic acid compositions for dermatological use
|
CA2792729C
(en)
|
2010-03-12 |
2016-06-28 |
Allergan Industrie, Sas |
Fluid compositions for improving skin conditions
|
AU2011227006A1
(en)
|
2010-03-19 |
2012-10-04 |
Revent Medical Inc. |
Systems and methods for treatment of sleep apnea
|
WO2011116384A2
(en)
*
|
2010-03-19 |
2011-09-22 |
Revent Medical, Inc. |
Systems and methods for treatment of sleep apnea
|
EP3078388B1
(de)
|
2010-03-22 |
2019-02-20 |
Allergan, Inc. |
Vernetzte hydrogele zur weichgewebevergrösserung
|
US9987114B2
(en)
|
2010-03-24 |
2018-06-05 |
Covidien Lp |
Combination three-dimensional surgical implant
|
SA111320355B1
(ar)
|
2010-04-07 |
2015-01-08 |
Baxter Heathcare S A |
إسفنجة لايقاف النزف
|
EP2571464A4
(de)
|
2010-05-21 |
2014-08-06 |
Revent Medical Inc |
Systeme und verfahren zur behandlung von schlafapnoe
|
KR20130083393A
(ko)
|
2010-06-01 |
2013-07-22 |
백스터 인터내셔널 인코포레이티드 |
건조 및 안정한 지혈 조성물의 제조 방법
|
CA2801120C
(en)
|
2010-06-01 |
2019-08-20 |
Baxter International Inc. |
Process for making dry and stable hemostatic compositions
|
AU2011260258B2
(en)
|
2010-06-01 |
2015-07-09 |
Baxter Healthcare S.A. |
Process for making dry and stable hemostatic compositions
|
EP2598091A4
(de)
|
2010-07-26 |
2014-08-20 |
Revent Medical Inc |
Systeme und verfahren zur behandlung von schlafapnoe
|
US8697057B2
(en)
|
2010-08-19 |
2014-04-15 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US8883139B2
(en)
|
2010-08-19 |
2014-11-11 |
Allergan Inc. |
Compositions and soft tissue replacement methods
|
US8889123B2
(en)
|
2010-08-19 |
2014-11-18 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US9005605B2
(en)
|
2010-08-19 |
2015-04-14 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US9447169B2
(en)
|
2011-03-04 |
2016-09-20 |
Orthovita, Inc. |
Flowable collagen-based hemostat and methods of use
|
US9393263B2
(en)
|
2011-06-03 |
2016-07-19 |
Allergan, Inc. |
Dermal filler compositions including antioxidants
|
US20130096081A1
(en)
|
2011-06-03 |
2013-04-18 |
Allergan, Inc. |
Dermal filler compositions
|
KR102238406B1
(ko)
|
2011-06-03 |
2021-04-08 |
알러간 인더스트리 에스에이에스 |
항산화제를 포함하는 피부 충전제 조성물
|
US9408797B2
(en)
|
2011-06-03 |
2016-08-09 |
Allergan, Inc. |
Dermal filler compositions for fine line treatment
|
US9662422B2
(en)
|
2011-09-06 |
2017-05-30 |
Allergan, Inc. |
Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
|
US20130244943A1
(en)
|
2011-09-06 |
2013-09-19 |
Allergan, Inc. |
Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
|
MX356185B
(es)
|
2011-10-11 |
2018-05-17 |
Baxter Int |
Composiciones hemostaticas.
|
AU2012318258B2
(en)
|
2011-10-11 |
2015-07-09 |
Baxter Healthcare S.A. |
Hemostatic compositions
|
AU2012330450B2
(en)
|
2011-10-27 |
2017-04-27 |
Baxter Healthcare Sa |
Hemostatic compositions
|
EP2822474B1
(de)
|
2012-03-06 |
2018-05-02 |
Ferrosan Medical Devices A/S |
Druckbehälter mit einer blutstillenden paste
|
US20230270916A1
(en)
*
|
2012-03-14 |
2023-08-31 |
MAM Holdings of West Florida, L.L.C. |
Collagen compositions and uses for biomaterial implants
|
EP2977066A3
(de)
|
2012-06-12 |
2016-07-27 |
Ferrosan Medical Devices A/S |
Trockene blutstillende zusammensetzung
|
DE102012213496A1
(de)
*
|
2012-07-31 |
2014-05-15 |
Amedrix Gmbh |
Kit, dessen Verwendung und Verfahren zum Auffüllen von Bindegewebe der Haut
|
JP6382854B2
(ja)
|
2013-03-04 |
2018-08-29 |
ダーメル,リミティド ライアビリティ カンパニー ディー/ビー/エー エターノジェン,リミティド ライアビリティ カンパニー |
InSituで重合する注射可能なコラーゲン組成物
|
EP3010419B1
(de)
|
2013-06-21 |
2020-05-20 |
Ferrosan Medical Devices A/S |
Vakuumerweiterte trockenzusammensetzung und spritze zum zurückhalten davon
|
AU2014361291B2
(en)
|
2013-12-11 |
2017-11-30 |
Ferrosan Medical Devices A/S |
Dry composition comprising an extrusion enhancer
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
US10722444B2
(en)
|
2014-09-30 |
2020-07-28 |
Allergan Industrie, Sas |
Stable hydrogel compositions including additives
|
JP6726852B2
(ja)
|
2014-10-13 |
2020-07-22 |
フェッローサン メディカル ディバイス エー/エス |
止血および創傷治癒に使用するための乾燥組成物
|
JP6747650B2
(ja)
|
2014-12-24 |
2020-08-26 |
フェロサン メディカル デバイシーズ エイ/エス |
第1の物質と第2の物質を保持し混合するためのシリンジ
|
WO2016128783A1
(en)
|
2015-02-09 |
2016-08-18 |
Allergan Industrie Sas |
Compositions and methods for improving skin appearance
|
FR3033697B1
(fr)
*
|
2015-03-17 |
2020-03-27 |
Universite Pierre Et Marie Curie (Paris 6) |
Suspensions de collagene injectables, leur procede de preparation et leurs utilisations, notamment pour la formation de matrices denses de collagene
|
EP3302354B1
(de)
|
2015-06-03 |
2023-10-04 |
i2o Therapeutics, Inc. |
Systeme zum einsetzen eines implantats
|
JP6747651B2
(ja)
|
2015-07-03 |
2020-08-26 |
フェロサン メディカル デバイシーズ エイ/エス |
保管状態で真空を保持するための、及び2種の成分を混合するためのシリンジ
|
BR112018073511A2
(pt)
|
2016-05-16 |
2019-03-26 |
Intarcia Therapeutics, Inc. |
polipeptídeos seletivos do receptor de glucagon e métodos de uso dos mesmos
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
CN110225762A
(zh)
|
2017-01-03 |
2019-09-10 |
因塔西亚制药公司 |
包括glp-1受体激动剂的连续施用和药物的共同施用的方法
|
MX2019010731A
(es)
|
2017-03-09 |
2019-11-01 |
Baxter Int |
Sistema y metodos de deposicion de disolventes.
|
EP4321182A2
(de)
|
2018-05-09 |
2024-02-14 |
Ferrosan Medical Devices A/S |
Verfahren zur herstellung einer hämostatischen zusammensetzung
|